Please try another search
Dawnrays Pharmaceutical (Holdings) Limited, an investment holding company, develops, manufactures, and sells non-patented pharmaceutical medicines in Mainland China and internationally. It operates in two segments, Intermediates and Bulk Medicines, and Finished Drugs. The company offers antibiotics, including pharmaceutical intermediates, bulk medicines, powder for injections, and oral antibiotics. It also provides and system specific medicines comprising cardiovascular systems; anti-allergic, anti-HBV, and digestive systems; urinary systems; and anti-pyretic analgesic, respiratory, and endocrine system drugs in the form of tablets, capsules, and granules. Dawnrays Pharmaceutical (Holdings) Limited was founded in 1995 and is headquartered in Wan Chai, Hong Kong.
Name | Age | Since | Title |
---|---|---|---|
Kei Ling Li | 72 | 1995 | Co-Founder & Executive Chairman |
Hong Man Leung | 48 | 2005 | Non-Executive Director |
Hao Xi Ede | 63 | 2015 | Independent Non-Executive Director |
Ming Yee Lam | 53 | 2018 | Independent Non-Executive Director |
Tung Sing Lo | 53 | 2010 | Independent Non-Executive Director |
Yung Lai Hung | 79 | 1995 | Co-Founder & Executive Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review